Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Tenaya Therapeutics IncCommon Stock stock
Learn how to easily invest in Tenaya Therapeutics IncCommon Stock stock.
Tenaya Therapeutics Inc. Common Stock is a biotechnology business based in the US. Tenaya Therapeutics IncCommon Stock shares (TNYA) are listed on the NASDAQ and all prices are listed in US Dollars. Tenaya Therapeutics IncCommon Stock employs 100 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Tenaya Therapeutics IncCommon Stock
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – TNYA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Tenaya Therapeutics IncCommon Stock stock price (NASDAQ: TNYA)Use our graph to track the performance of TNYA stocks over time.
Tenaya Therapeutics IncCommon Stock shares at a glance
|Latest market close||$10.00|
|52-week range||$11.21 - $32.00|
|50-day moving average||$20.74|
|200-day moving average||$21.26|
|Wall St. target price||$35.67|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-7.47|
Buy Tenaya Therapeutics IncCommon Stock shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Tenaya Therapeutics IncCommon Stock stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Tenaya Therapeutics IncCommon Stock price performance over time
|1 week (2022-01-07)||-26.20%|
|1 month (2021-12-16)||-50.57%|
|3 months (2021-10-15)||-51.36%|
|6 months (2021-07-12)||N/A|
|1 year (2021-01-12)||N/A|
|2 years (2020-01-12)||N/A|
|3 years (2019-01-12)||N/A|
|5 years (2017-01-12)||N/A|
Tenaya Therapeutics IncCommon Stock financials
|Gross profit TTM||$0|
|Return on assets TTM||0%|
|Return on equity TTM||0%|
|Market capitalisation||$477.2 million|
TTM: trailing 12 months
Tenaya Therapeutics IncCommon Stock share dividends
We're not expecting Tenaya Therapeutics IncCommon Stock to pay a dividend over the next 12 months.
Tenaya Therapeutics IncCommon Stock overview
Tenaya Therapeutics, Inc. develops therapeutics for heart failure. It offers cellular regeneration platform, that enables in vivo reprogramming of cardiac fibroblasts into cardio myocytes by delivering proprietary transcription factors; gene therapy platform, that enables the targeted delivery of a payload to cardiac fibroblasts; and precision medicine platform, which provides personalized medicine approach to treat heart disease. The company was incorporated in 2016 and is based in South San Francisco, California. .
Tenaya Therapeutics IncCommon Stock in the news
Stocks That Hit 52-Week Lows On Friday
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
Frequently asked questionsWhat percentage of Tenaya Therapeutics IncCommon Stock is owned by insiders or institutions?
Currently 12.591% of Tenaya Therapeutics IncCommon Stock shares are held by insiders and 80.016% by institutions. How many people work for Tenaya Therapeutics IncCommon Stock?
Latest data suggests 100 work at Tenaya Therapeutics IncCommon Stock. When does the fiscal year end for Tenaya Therapeutics IncCommon Stock?
Tenaya Therapeutics IncCommon Stock's fiscal year ends in December. Where is Tenaya Therapeutics IncCommon Stock based?
Tenaya Therapeutics IncCommon Stock's address is: 171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 What is Tenaya Therapeutics IncCommon Stock's ISIN number?
Tenaya Therapeutics IncCommon Stock's international securities identification number is: US87990A1060
More guides on Finder
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
NFT-funded LinksDAO moves $10.5 million closer to buying a golf course
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.
How to buy Nexalin Technology (NXL) stock when it goes public
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
How to buy Specialty Building Products (SBP) stock when it goes public
Everything we know about the Specialty Building Products IPO, plus information on how to buy in.
How to buy HeartCore Enterprises (HTCR) stock when it goes public
Everything we know about the HeartCore Enterprises IPO, plus information on how to buy in.
Ask an Expert